Vice President, Global Program & Portfolio Lead, Immune Enhancers & Cell Engagers
Takeda
Cambridge, Massachusetts
Meena Subramanyam, Ph.D., is an innovative scientific leader in the biopharmaceutical industry with extensive experience in drug development and translational sciences. She has contributed to the approval of eight first-in-class therapeutics and has published extensively in top-ranked peer-reviewed scientific journals on drug development, clinical biomarkers, pharmacokinetics/pharmacodynamics of therapeutics, bioanalytical methods, and clinical impact of immunogenicity. She has collaborated extensively with scientific thought leaders and has co-authored white papers with representatives from academia, industry, and U.S. and international regulatory agencies. She is also a named inventor on several patents. Subramanyam is a recipient of the Healthcare Business Women Association’s Luminary Award and the AAPS Global Leader Award. She has been a member of the U.S. Pharmacopeia experts committee, the International Cytokines Standards Committee, and of AAPS for over 20 years, and served as conference chair of the 2017 and 2021 AAPS National Biotechnology Meeting. She has served as President of the board of WEST, a Boston-based organization for the empowerment of women, and continues to serve as member on several not-for-profit boards. In her current role at Takeda Oncology, she oversees the strategic development of therapeutic assets with potential to enhance the capacity of the immune system to fight cancers.
Work-Life Harmony for Women: Strategies for Supporting Each Other
Tuesday, October 24, 2023
1:30 PM – 2:30 PM ET
Global Leadership: Inclusivity and Empathy for Multicultural Team
Wednesday, October 25, 2023
9:00 AM – 10:00 AM ET